REMS assessments: clinical settings REMS technology is recognized as useful tool in the management of osteoporosis and fracture prevention. Its portability and lack of ionizing radiation means it can be used in previously underserved populations, including pregnant...
POLAND: REMS IN THE RECOMMENDATIONS FOR THE DIAGNOSIS AND TREATMENT OF OSTEOPOROSIS The 2026 recommendations for the Diagnosis and treatment of Osteoporosis in Poland have been now published in the scientific journal Rheumatology (2026 edition) “Diagnosis and...
REMS: capable of providing information that goes beyond anthropometric modelling alone “The manuscript entitled “Methodological clarification and analysis of demographic and anthropometric determinants in the calculation of REMS bone mineral density”, authored by...
The Advantages of REMS Technology in Type 2 Diabetes Mellitus The study “Utility of REMS-Derived Fragility Score and Trabecular Bone Score in Evaluating Bone Health in Type 2 Diabetes Mellitus” recently published by Al Refaie and colleagues in Diagnostics Journal...
REMS and DXA meta-analysis The prestigious article “Correlation between Radiofrequency Echographic Multi-Spectrometry (REMS) and dual-energy X-ray absorptiometry (DXA): A systematic review and meta-analysis” by Ryan Yan Liu and Enwu Liu very recently published on Bone...
The use of non-ionizing REMS technology supports longitudinal monitoring in AIs-treated BC patients The study “Longitudinal monitoring of denosumab-associated bone changes by REMS in postmenopausal women with ER-positive breast cancer receiving aromatase inhibitors”,...
Recent Comments